Department of Diagnostic Imaging, University Hospital Tor Vergata, Molecular Imaging, Interventional Radiology and Radiation Therapy, Viale Oxford, 81 - 00133, Rome, Italy.
Catheter Cardiovasc Interv. 2013 Sep 1;82(3):485-92. doi: 10.1002/ccd.24742. Epub 2013 Mar 14.
To assess the efficacy and safety of the Outback device in patients with a chronic total occlusion (CTO) of the superficial femoral artery and evaluate its impact on fluoroscopy and procedural times.
From October 2006 to March 2007, 52 patients affected by TASC II-D superficial femoral artery CTO were treated with subintimal recanalization. Clinical indications for endovascular recanalization were: claudication, tissue loss, and at rest leg pain with critical limb ischemia. In 26 patients the manual reentry technique was used and in 26 the OUTBACK(®) LTD Re-Entry Catheter was used. Total procedure time, fluoroscopy time and precision in targeting the expected reentry site have been compared.
Technical success was achieved in all cases (100%). In group 2, the planned in-target re-entry was achieved in 11/26 cases (42.3%). The procedure was performed with a traditional antegrade approach in 23/26 (88.4%) cases and in three cases (11.6%) a combined antegrade/retrograde approach was necessary. In group 1, the in-target re-entry was achieved in 26/26 cases (100%). In group 2, the mean procedural time was 55.4 ± 14.2 min with a mean fluoroscopy time 39.6 ± 13.9 min compared to 36.0 ± 9.4 min and 29.8 ± 8.9 min, respectively, of group 1 (P < 0.0001).
In our experience, the use of this device is very useful for the revascularization of chronic femoral occlusions, even calcific, in which an accurate re-entry cannot be achieved with the conventional subintimal technique. In these cases, the Outback device grants high technical success rates and a significant reduction of procedural and fluoroscopy times.
评估 Outback 装置在股浅动脉慢性完全闭塞(CTO)患者中的疗效和安全性,并评估其对透视和手术时间的影响。
2006 年 10 月至 2007 年 3 月,52 例 TASC II-D 股浅动脉 CTO 患者接受了内膜下再通治疗。血管内再通的临床适应证为:跛行、组织丧失和静息时腿部疼痛伴严重肢体缺血。26 例患者采用手动再入技术,26 例患者采用 OUTBACK(®) LTD 再入导管。比较了总手术时间、透视时间和靶向预期再入部位的准确性。
所有病例均获得技术成功(100%)。在第 2 组中,11/26 例(42.3%)达到了计划的靶位再入。23/26 例(88.4%)采用传统顺行入路进行手术,3 例(11.6%)需要联合顺行/逆行入路。第 1 组中,26/26 例(100%)达到了靶位再入。第 2 组的平均手术时间为 55.4±14.2min,透视时间为 39.6±13.9min,而第 1 组分别为 36.0±9.4min 和 29.8±8.9min(P<0.0001)。
根据我们的经验,在常规内膜下技术无法准确再入的情况下,该装置对于慢性股动脉闭塞(甚至是钙化性闭塞)的再血管化非常有用。在这些情况下,Outback 装置可获得较高的技术成功率,并显著减少手术时间和透视时间。